Send CathInfo's owner Matthew a gift from his Amazon wish list:
https://www.amazon.com/hz/wishlist/ls/25M2B8RERL1UO

Author Topic: HIV-like "mutation" in coronavirus  (Read 123 times)

0 Members and 1 Guest are viewing this topic.

Offline Parasitic Eww

  • Newbie
  • *
  • Posts: 105
  • Reputation: +45/-71
  • Gender: Male
HIV-like "mutation" in coronavirus
« on: February 27, 2020, 05:13:05 PM »
  • Thanks!0
  • No Thanks!0
  • The liars say it's a "mutation", but in reality it's genetic engineering that spliced the HIV protein into the coronavirus.

    Anyway, I told you all that this coronavirus has an HIV protein and it's essentially HIV that spreads like measles or flu, but most of you didn't want to listen. Now, the mainstream sources are coming around to admitting that it's "HIV-like", but they won't admit it's genetically engineered.

    Fact is HIV doesn't exchange genetic material with coronavirus in nature. This thing came from a lab.

    https://www.scmp.com/news/china/society/article/3052495/coronavirus-far-more-likely-sars-bond-human-cells-scientists-say

    Quote
    Coronavirus far more likely than Sars to bond to human cells due to HIV-like mutation, scientists say

        Research by team from Nankai University shows new virus has mutated gene similar to those found in HIV and Ebola
        Finding may help scientists understand how the infection spreads and where it came from
    -------------

    The new coronavirus
    has an HIV-like mutation that means its ability to bind with human cells could be up to 1,000 times as strong as the Sars virus, according to new research by scientists in China and Europe.

    The discovery could help to explain not only how the infection has spread but also where it came from and how best to fight it.

    Scientists showed that Sars (severe acute respiratory syndrome) entered the human body by binding with a receptor protein called ACE2 on a cell membrane. And some early studies suggested that the new coronavirus, which shares about 80 per cent of the genetic structure of Sars, might follow a similar path.

    But the ACE2 protein does not exist in large quantities in healthy people, and this partly helped to limit the scale of the Sars outbreak of 2002-03, in which infected about 8,000 people around the world.

    Other highly contagious viruses, including HIV and Ebola, target an enzyme called furin, which works as a protein activator in the human body. Many proteins are inactive or dormant when they are produced and have to be “cut” at specific points to activate their various functions.

    The virus uses the outreaching spike protein to hook on to the host cell, but normally this protein is inactive. The cleavage site structure’s job is to trick the human furin protein, so it will cut and activate the spike protein and cause a “direct fusion” of the viral and cellular membranes.

    Compared to the Sars’ way of entry, this binding method is “100 to 1,000 times” as efficient, according to the study.

    Just two weeks after its release, the paper is already the most viewed ever on Chinarxiv.

    In a follow-up study, a research team led by Professor Li Hua from Huazhong University of Science and Technology in Wuhan, Hubei province, confirmed Ruan’s findings.

    [...]


    Offline Parasitic Eww

    • Newbie
    • *
    • Posts: 105
    • Reputation: +45/-71
    • Gender: Male
    Re: HIV-like "mutation" in coronavirus
    « Reply #1 on: February 27, 2020, 05:34:07 PM »
  • Thanks!0
  • No Thanks!0
  • Here's the study showing the HIV protein spliced into the coronavirus. If you click on the link, a new banner is attached to the paper indicating it has been withdrawn. The Jєωs pressured the researchers to withdraw their findings. LOL ... "For fear of the Jєωs" (John 7:13)

    https://www.biorxiv.org/content/10.1101/2020.01.30.927871v1

    Quote
    We are currently witnessing a major epidemic caused by the 2019 novel coronavirus (2019-nCoV). The evolution of 2019-nCoV remains elusive. We found 4 insertions in the spike glycoprotein (S) which are unique to the 2019-nCoV and are not present in other coronaviruses. Importantly, amino acid residues in all the 4 inserts have identity or similarity to those in the HIV-1 gp120 or HIV-1 Gag. Interestingly, despite the inserts being discontinuous on the primary amino acid sequence, 3D-modelling of the 2019-nCoV suggests that they converge to constitute the receptor binding site. The finding of 4 unique inserts in the 2019-nCoV, all of which have identity /similarity to amino acid residues in key structural proteins of HIV-1 is unlikely to be fortuitous in nature. This work provides yet unknown insights on 2019-nCoV and sheds light on the evolution and pathogenicity of this virus with important implications for diagnosis of this virus.